Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCRTR1 | O43613 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | CA2 | P00918 | 2/20 | 0.47 |
| ▸ | CA1 | P00915 | 1/20 | 0.47 |
| ▸ | BCHE | P06276 | 1/20 | 0.47 |
| ▸ | ACHE | P22303 | 1/20 | 0.47 |
| ▸ | CES2 | O00748 | 1/20 | 0.44 |
| ▸ | CES1 | P23141 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.42 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.42 |
| ▸ | PARP1 | P09874 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 2/20 | 0.42 |
| ▸ | RAB9A | P51151 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21875954 | 0.93 | HCRTR1 (0.48) | HCRTR1MEN1POLBGAAKMT2A | |
| SCHEMBL7772917 | 0.93 | MEN1 (0.54) | HCRTR1MEN1POLBGAAKMT2A | |
| SCHEMBL23163313 | 0.85 | HCRTR1 (0.59) | HCRTR1POLBGAACA2CA1 | |
| SCHEMBL1727475 | 0.83 | GAA (0.53) | MEN1POLBGAAKMT2ACA2 | |
| SCHEMBL20710745 | 0.82 | CA1 (0.62) | MEN1POLBGAAKMT2ACA2 | |
| SCHEMBL11763718 | 0.82 | HCRTR1 (0.56) | HCRTR1POLBGAACA2CA1 | |
| SCHEMBL22619019 | 0.81 | MEN1 (0.47) | MEN1POLBGAAKMT2ACA2 | |
| SCHEMBL27822413 | 0.81 | POLB (0.47) | MEN1POLBGAAKMT2ACA2 | |
| Phosphoric Acid Diethyl Ester Phenyl Ester SCHEMBL133234 | 0.80 | CA1 (0.59) | MEN1POLBGAAKMT2ACA2 | |
| SCHEMBL20710747 | 0.79 | PKM (0.53) | POLBCA2CA1BCHEACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104496769-B | A kind of 2-[2-(3-methoxyl group-phenyl)-ethyl] synthetic method of-phenol | Wan Hui Pharmaceutical (Anhui) Co., Ltd. (CN) | 2016-05-11 | — | — | CN | claimed |
| EP-3647315-B9 | PHOSPHORUS-CONTAINING COMPOUND AND PREPARATION AND USE THEREOF | VIVAVISION BIOTECH LTD (CN) | 2025-06-04 | — | — | EP | disclosed |
| EP-3647315-B1 | PHOSPHORUS-CONTAINING COMPOUND AND PREPARATION AND USE THEREOF | VIVAVISION BIOTECH LTD (CN) | 2024-11-20 | — | — | EP | disclosed |
| US-11325929-B2 | Phosphorus-containing compound and preparation and use thereof | VIVAVISIONSHANGHAILTD (CN) | 2022-05-10 | — | — | US | disclosed |
| CN-109134533-B | Phosphorus-containing compound and preparation and application thereof | 维眸生物科技（上海）有限公司 | 2020-08-11 | — | — | CN | disclosed |
| EP-3647315-A1 | PHOSPHORUS-CONTAINING COMPOUND AND PREPARATION AND USE THEREOF | Vivavisionshanghailtd (CN) | 2020-05-06 | — | — | EP | disclosed |
| US-20200131206-A1 | PHOSPHORUS-CONTAINING COMPOUND AND PREPARATION AND USE THEREOF | VIVAVISIONSHANGHAILTD (CN) | 2020-04-30 | — | — | US | disclosed |
| CN-109134533-A | A kind of phosphorus-containing compound and its preparation and application | 维眸生物科技（上海）有限公司 | 2019-01-04 | — | — | CN | disclosed |
| CN-104496769-B | A kind of 2-[2-(3-methoxyl group-phenyl)-ethyl] synthetic method of-phenol | Wan Hui Pharmaceutical (Anhui) Co., Ltd. (CN) | 2016-05-11 | — | — | CN | disclosed |
| CN-104496769-B | A kind of 2-[2-(3-methoxyl group-phenyl)-ethyl] synthetic method of-phenol | Wan Hui Pharmaceutical (Anhui) Co., Ltd. (CN) | 2016-05-11 | — | — | CN | disclosed |
| CN-102757463-A | Method for preparing aryl dialkyl phosphate from aryl sulfonate | UNIV SHANGHAI JIAOTONG | 2012-10-31 | — | — | CN | disclosed |
| US-5488172-A | Chiral phosphorus compounds | HOFFMANN-LA ROCHE INC. (US) | 1996-01-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11325929-B2 | Phosphorus-containing compound and preparation and use thereof | INPP5D, CXCL12, INPPL1 | HCRTR1 3611/4885MEN1 3056/4885POLB 2721/4885 |
| US-20200131206-A1 | PHOSPHORUS-CONTAINING COMPOUND AND PREPARATION AND USE THEREOF | INPP5D, CXCL12, INPPL1 | HCRTR1 3611/4885MEN1 3056/4885POLB 2721/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.